Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00681928 · ClinicalTrials.gov registry record

Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

A clinical trial, sponsored by City of Hope Medical Center.

Completed
Registry status
72
Enrollment target

NCT00681928: Completed study, sponsored by City of Hope Medical Center.

NCT00681928 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00681928 has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
72 participants
Enrollment target

Study Summary

RATIONALE: Gathering information about cognitive function over time in postmenopausal women with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor therapy and plan the best treatment. PURPOSE: This clinical trial is studying cognitive function in older postmenopausal women with stage I, stage II, or stage III breast cancer receiving hormone therapy and in healthy volunteers.

Interventions

  • DRUG letrozole
  • OTHER questionnaire administration
  • DRUG anastrozole
  • PROCEDURE cognitive assessment
  • PROCEDURE psychosocial assessment and care

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2007-10
Est. Completion 2011-01
City of Hope Medical Center

582 total trials

What the finished NCT00681928 record still lists

NCT00681928 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which letrozole is the first listed.

NCT00681928 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00681928 about?

NCT00681928 is a clinical study titled "Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy". RATIONALE: Gathering information about cognitive function over time in postmenopausal women with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor therapy and plan the best treatment. PURPOSE: This clinical trial is studying cognitive function in older postmeno...

What is the current status of trial NCT00681928?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2007-10. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00681928?

The interventions under investigation include: letrozole (DRUG), questionnaire administration (OTHER), anastrozole (DRUG), cognitive assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).

Who is sponsoring clinical trial NCT00681928?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00681928, the US trial registry maintained by the National Library of Medicine. NCT00681928 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.